Gynecology, Obstetrics and Infertility | Conference Series | International Scientific and Medical Conferences

Theme: An Insight into Clinical and Research Advancements in Gynecology and Obstetrics

Gynecology Meeting 2019

Gynecology Meeting 2019

7^th International Congress on Gynecology & Gynecologic Oncology

Dates: June 20-21, 2019

Venue: London, UK

After successful completion of Gynecology Meeting 2018 with great privilege and honor on behalf of the Organizing Committee we would take the opportunity to invite worlwide speakers at “7^th International Congress on Gynecology & Gynecologic Oncology” (Gynecology Meeting2018).The Gynecology Conferences will enlighten the world with recent advances in Gynecology and Gynecologic oncology research and inculcate new ideas about healthy living. Moreover, this Gynecology Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the gynecology research fields are the unique attributes of this conference. Gynecology conferences, symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Gynecology and Gynecologic Oncology.

Gynecology Meeting 2019 conference will be host by ConferenceSeries llc Ltd which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

ConferenceSeries llc Ltd is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

ConferenceSeries llc Ltd organising a wide range of Gynecology Conferences, Gynecologic meetings, Gynecologic Oncology Conferences, Surgical Gynecology, like Breast Cancer Conferences, Gynecology Cancer Conferences, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend Gynecology Meeting 2019?

With members from around the world focused on learning about Gynecologic and Gynecologic Cancer this is best opportunity to reach the largest assemblage of participants from the world like as: societies, universities, research groups, scientists, researchers, PhD scholars, who will Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Gynecologic Cancer Conferences,which are also the hallmarks of this conference.

Target Audience

Oncologists
Gynaecologists
Radiologists
Pathologists
Scientists
Students
Researchers
Faculty
Gynecology Cancer Associations and Societies
Business Entrepreneurs
Training Institutes
Pharmaceutical Companies
Medical Devices Companies

Track 1: Gynecology and Obstetrics

Gynecology and obstetrics are the studies of the female reproductive system. Obstetrics is the branch of medicine that focuses on women during pregnancy, childbirth, and the postpartum period. Gynecology is a broader field, focusing on the general health care of women and treating conditions that affect the female reproductive organs. Doctors who are specialized in gynecology and obstetrics will have to undergo four years of post-medical school training in the areas of women’s general health, pregnancy, labor and delivery, preconception and postpartum care, prenatal testing, and genetics. For example, women may be referred as gynecologists in the earlier stages of pregnancy, and obstetricians later in their term.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Related Conferences: 6^th International Congress on Gynecology Conferences & Gynecologic Oncology Conferences; 29th Cancer Therapy Conferences and Radiation Oncology Conferences, July 23-25, 2018 Rome, Italy; 28th Euro Cancer Science and Therapy Conferences, August 09-10, 2018 Madrid, Spain, May 10-12, 2018 Frankfurt, Germany; 9th European Immunology Conferences , June 14-16, 2018 Rome, Italy; 12th World Hematologists Conferences , March 15-16, 2018 London, UK; 14th International Surgical Pathology Conferences and Cancer Diagnosis Conferences, May 17-18, 2018 Rome, Italy; 7th World Breast Cancer Conferences, May 10-11, 2018 Frankfurt, Germany; 20th International Pediatrics Primary Care Conferences, September 03-04, 2018 Zurich, Switzerland; Annual Conference on Clinical Conferences and Medical Case Reports in Cardiology Conferences, July 05-06, 2018 Frankfurt, Germany; 47^th Global Nursing and Healthcare Conferences, March 01-03, 2018, London, UK; 7^th World Breast Cancer Conferences, May 10-11, 2018, Frankfurt, Germany; 26th Cancer Nursing & Nurse Practitioners Conferences, July 16-17, 2018, London, UK; 2nd World Patient Safety & Quality Healthcare Conferences, June 21-22, 2018, Dublin, Ireland

Track 2: Gynecologic Oncology

Gynecologic oncology is specifying the field of medicine that emphases on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers. A Gynecologic oncologist is a gynaecologist who specializes in the diagnosis and treatment of women with cancer of the reproductive organs. Specifically, the Gynecologic oncologist treats cancer of the ovary, endometrium, uterus, cervix, vagina, vulva and trophoblastic disease.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 3: Gynecologic Diseases

Vaginal symptoms may also be a sign of more serious problems, from sexually transmitted diseases (STDs) to cancers of the reproductive tract. Gynecological symptoms may resemble other medical conditions or urological problems. But, if they are not treated properly, they can lead to more serious conditions, including infertility or kidney damage. From puberty through menopause, a woman's reproductive organs are constantly changing through the normal processes of sexual activity, pregnancy and aging, and sometimes disease and injury. All over the world doctors provide individualized, specialized care aimed at maintaining health, preventing illness and treating disease. Vaginal bleeding and discharge are a normal part of your menstrual cycle prior to menopause. However, if you notice anything different or unusual, consult your physician before attempting to treat the problem yourself. Symptoms may result from mild infections that are easy to treat.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 4: Women Cancer

Cancers that originates in the female reproductive part is known as women cancer or Gynecologic Cancer. The women cancer includes cervical cancer, ovarian cancer, breast cancer, endometrial/uterine cancer, vaginal/ vulva cancer. Gynecologic cancer is unique, with different signs and symptoms, different risk factors, and different prevention strategies. All women are at risk for Gynecologic cancers, and risk increases with age. In the early stage treatment of Gynecology cancers is most effective.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 5: Human papilloma Virus

HPV is consists of more than 150 related viruses. Some HPV types can cause cancer, especially cervical cancer. There are more than 40 HPV types that can infect the genital areas of males and females. But there are vaccines that can prevent infection with the most common types of HPV. HPV can transmit by having vaginal, anal, or oral sex with someone who has the virus. It is most commonly spread during vaginal or anal sex.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 6: HPV Vaccines

There are three vaccines which are approved by the FDA to prevent HPV infection: Gardasil, Gardasil 9, and Cervarix. All three vaccines prevent infections with HPV types 16 and 18, two high-risk HPV that cause 70% of cervical cancers and an even higher p ercentage of some of the other HPV-associated cancer. Gardasil also prevents infection with HPV types 6 and 11, which cause 90% of genital warts.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 7: Cervical Cancer

Cervical Cancer is one of the most common cancers in women worldwide. But in the United States and other countries where cervical cancer screening is routine, this cancer is not so common. Most cervical cancer is caused by a virus called Human papillomavirus, or HPV. There are many types of the HPV virus. Not all types of HPV cause cervical cancer. Some of them cause genital warts, but other types may not show any Cervical Cancer symptoms and signs. An infection may go away on its own. But sometimes it can cause genital warts or lead to cervical cancer. That's why it's important for women to have regular Pap tests. A Pap test can find changes in cervical cells before they turn into cancer cells. If you treat these cell changes, you may prevent cervical cancer.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 8: Reproductive Medicine

Reproductive Medicine in Gynecology is ever growing area. The number of Research institutes which are working on reproductive medicine are approximately 120 and the number of Universities are around 20-30 which have the department of Medicine and the funding towards this research is over $90000 - $110000, Target audience are of Academia 20%, 50% industry and 30% of others. Reproductive medicine is a branch of medicine which focuses on prevention, diagnosis and management of the reproductive problems. The goals include improving or maintaining reproductive health and allowing people to have children at a time of their choice as discussed in many gynecologic conferences and gynecologic meetings worldwide. It is focused on knowledge of reproductive anatomy, physiology and endocrinology which also incorporates relevant aspects of molecular biology, biochemistry and pathology. Regenerative medicine emphasizes on process of replacing, engineering or regenerating human cells, tissues or organs to restore/establish normal function.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 9: Infertility

Infertility can be described as a woman who is unable to conceive as well as being unable to carry a pregnancy to full term. Infertility is the inability of a person, plant or an animal to reproduce by natural means. It is normally not the innate state of a healthy adult organism, except in particularly among certain eusocial species (predominantly haplodiploid insects). Understanding the socio demographic factors parallel with use may assist newly married couples with family planning. As discussed in many gynecologic conferences and gynecologic meetings worldwide, the use of infertility services is not random and roughly about 50% of the women evaluated for infertility progressed to treatment, and in which only a small proportion were treated with additional advanced assisted reproductive technologies essentially Invitro fertilization. Obesity in reproductive health will centralize on two important areas which are infertility and heavy menstrual bleeding. Women who are fertile will experience a natural period of fertility before and during ovulation, and they will be naturally infertile during the latter part of the menstrual cycle. Medical and surgical management of heavy menstrual bleeding is described including the many varied issues in hysterectomy of obese woman.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 10: Gynecologic Surgery

Gynecologic Surgery is giving a fundamental, peer-assessed data for clinical articles managing all parts of agent and office gynecology. "Gynecological Surgery", established in 2004, is the first and head peer-surveyed logical diary devoted to all parts of research, advancement, and preparing in gynecological surgery. Gynecological surgery alludes to surgery on the female conceptive framework. It incorporates strategies for amiable conditions, malignancy, fruitlessness, and incontinence. Gynecological surgery may occasionally be performed for elective or restorative purposes. Also, this field is quickly changing because of new advancements and developments in endoscopy, apply autonomy, imaging and other interventional systems. Gynecological surgery presently envelops every surgical intercession relating to ladies' wellbeing, including uro-gynecology, oncology and fetal surgery.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 11: Ovarian Cancer

Ovarian cancer when cancer starts in the ovaries, it is called ovarian cancer. Women have two ovaries that are in the pelvis, one on each side of the uterus. The ovaries make female hormones and produce eggs. Ovarian cancer causes more deaths than any other cancer of the female reproductive system. Ovarian cancer often causes signs and symptoms, so it is important to pay attention to your body and know what is normal for you.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 12: Breast Cancer

Breast cancer starts when cells in the breast begin to grow out of control. These cells usually form a tumor that can often be seen on an x-ray or felt as a lump. The tumor is malignant (cancerous) if the cells can grow into (invade) surrounding tissues or spread to distant areas of the body. Breast cancer occurs almost entirely in women, but men can get it, too. Although many types of breast cancer can cause a lump in the breast, not all do. There are other symptoms of breast cancer you should watch out for and report to a health care provider.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 13: Endometrial Cancer

Endometrial cancer or uterine cancer when cancer starts in the uterus, it is called uterine cancer. The uterus is the pear-shaped organ in a woman’s pelvis. The uterus, also called the womb, is where the baby grows when a woman is pregnant. The most common type of uterine cancer is also called endometrial cancer because it forms in the lining of uterus, called the endometrium. When uterine cancer is found early, treatment works best.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 14: Gynecological Endocrinology

There are a large Number of Research institutes working on the Gynecological Endocrinology which are approximately 25 and the Number of Universities working on this topic are approximately 80 and funding for the research given by University or a research institute is around $20000 - $30000 including Academia 20%, 30% industry and Others 50%. Gynecological Endocrinology focuses on the treatment of disorders related to menstruation, fertility and menopause. Reproductive endocrinology and Fetal-Placental neuroendocrine development refers to a subspecialty that focuses on the biological causes and its interventional treatment of infertility and its development.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 15: Uro-Gynecology

Uro-gynecology is an extensive topic and is professional in gynecology and the number of Research institutes working on the Uro-gynecology are approximately 30 or more and some universities also give training to women on Uro-gynecology , total number of universities which focus on this area are approximately 70 and also obtain a funding of around $10000- $30000 and includes 10% industry, 30% of academia and Others 60% .It is a surgical sub-specialty of urology and gynecology. Uro-gynecology is also a subspecialty of Female Pelvic Medicine and Reconstructive Surgery. Uro-gynecology involves diagnosis and treatment of urinary incontinence and female pelvic floor disorders. Robotic-assisted surgery has evolved vastly over the past two decades with persistently improving technology, proving to assist surgeons in multiple subspecialty disciplines as discussed in many gynecologic conferences and gynecologic meetings worldwide.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 16: Gynecologic Cancer: Case Reports

Ladies with early cervical malignancies and pre-diseases often have no manifestations. Manifestations regularly don't start until a pre-tumor turns into a genuine intrusive disease and develops into adjacent tissue. At the point when this happens, the most widely recognized manifestations are: Abnormal vaginal dying, for example, seeping after sex (vaginal intercourse), seeping after menopause, draining and spotting amongst periods, and having longer or heavier (menstrual) periods than common. Seeping in the wake of douching, or after a pelvic exam is a typical side effect of cervical tumor however not pre-disease. A strange release from the vagina − the release may contain some blood and may happen between your periods or after menopause; Pain amid sex (vaginal intercourse).

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 17: Clinical Gynecologic Oncology

Gynecology Oncology is the learn about any disease that starts in a lady's regenerative organs. The five Gynecologic tumors begin in the lady's pelvis at better places. Every tumor is one of a kind by its indications, signs, hazard components and in their systems of aversion. All these five unique sorts of Gynecology Cancers chance increments with the age. At the point when these malignancies were analyzed at their initial stages, the treatment will be more efficient. The five noteworthy sorts of tumor influence a lady's regenerative organs are ovarian, uterine, cervical, vulvar, and vaginal growth. All these as a gathering are known as Gynecologic growths.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 18: Gynecologic Cancers: Signs and Symptoms

Gynecologic Cancer symptoms are mentioned as below:

Women with early cervical cancers and pre-cancers usually have no symptoms. Symptoms often do not begin until a pre-cancer becomes a true invasive cancer and grows into nearby tissue. When this happens, the most common symptoms are: Abnormal vaginal bleeding, such as bleeding after sex (vaginal intercourse), bleeding after menopause, bleeding and spotting between periods, and having longer or heavier (menstrual) periods than usual. Bleeding after douching, or after a pelvic exam is a common symptom of cervical cancer but not pre-cancer. An unusual discharge from the vagina − the discharge may contain some blood and may occur between your periods or after menopause; Pain during sex (vaginal intercourse).

Ovarian cancer may cause several signs and symptoms. The most common symptoms include

Bloating

Pelvic or abdominal pain

Trouble eating or feeling full quickly

Urinary symptoms such as urgency or frequency

These symptoms are also commonly caused by benign (non-cancerous) diseases and by cancers of other organs. If a woman has these symptoms more than 12 times a month, she should see her doctor, preferably a gynecologist.

Other symptoms of ovarian cancer can include:

Fatigue, Upset stomach, Back pain, Pain during sex, Constipation, Menstrual changes, Abdominal swelling with weight loss

Endometrial cancer Signs and Symptoms

The symptoms may include vaginal bleeding, such as a change in their periods or bleeding between periods or after menopause. This symptom can also occur with some non-cancerous conditions, but it is important to have a test. If you have gone through menopause already, it’s especially important to report any vaginal bleeding, spotting, or abnormal discharge to your doctor.

Pain in the pelvis, feeling a mass, and losing weight without trying can also be symptoms of endometrial cancer.

Vaginal cancer Signs and Symptoms

The may include:

· Abnormal vaginal bleeding (often after intercourse)

· Abnormal vaginal discharge

· A mass that can be felt

· Pain during intercourse

Having these symptoms does not always mean that you have cancer. In fact, these symptoms are more likely to be caused by something besides cancer, like an infection. The only way to know for sure what’s causing these problems is to see a health care professional.

Vulva cancer Signs and Symptoms

· Women with vulvar cancer may experience the following symptoms or signs. Sometimes, women with vulvar cancer do not show any of these symptoms.

· A lump or growth in or on the vulvar area

· A patch of skin that is differently textured or colored than the rest of the vulvar area

· Persistent itching, pain, soreness, or burning in the vulvar area

· Painful urination

· Bleeding or discharge that is not menstrual blood

· An ulcer that persists for more than one month

Breast Cancer Signs and Symptoms

The first symptoms of breast cancer are usually an area of thickened tissue in the woman's breast, or a lump. Most lumps are not cancerous; however, women should get them checked by a health care professional.

The symptoms include

· A lump in a breast

· A pain in the armpits or breast that does not seem to be related to the woman's menstrual period

· Pitting or redness of the skin of the breast; like the skin of an orange

· A rash around (or on) one of the nipples

· A swelling (lump) in one of the armpits

· An area of thickened tissue in a breast

· One of the nipples has a discharge; sometimes it may contain blood

· The nipple changes in appearance; it may become sunken or inverted

· The size or the shape of the breast changes

· The nipple-skin or breast-skin may have started to peel, scale or flake.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 19: Gynecologic Cancer: Treatment and Monitoring

Gynecologic Cancer Treatment may include

Surgery

Surgery is the removal of the tumor and surrounding tissue during an operation. A surgical oncologist is a doctor who specializes in treating cancer using surgery. A hysterectomy is the removal of the uterus and cervix. Hysterectomy can be either a simple hysterectomy, which is the removal of the uterus and cervix, or a radical hysterectomy which is the removal of the uterus, cervix, upper vagina, and the tissue around the cervix.

Radiation therapy

Radiation therapy is the use of high-energy x-rays or other particles to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a Radiation Oncologist. Radiation therapy may be given alone, before surgery, or instead of surgery to shrink the tumor. Many women may be treated with a combination of radiation therapy and chemotherapy.

Chemotherapy

Chemotherapy is the use of drugs to destroy cancer cells, usually by stopping the cancer cells ability to grow and divide. Chemotherapy is given by a medical oncologist, a doctor who specializes in treating cancer with medication. Systemic chemotherapy is delivered through the bloodstream to reach cancer cells throughout the body. Common ways to give chemotherapy include an intravenous (IV) tube placed into a vein using a needle or in a pill or capsule that is swallowed (orally).

Immunotherapy

Another avenue of immunotherapy for Gynecologic and cervical cancers is adoptive T cell transfer. In this approach, T cells are removed from a patient, genetically modified or treated with chemicals to enhance their activity, and then re-introduced into the patient with the goal of improving the T cell immune system’s anti-cancer response.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Related Association & Society: 6^th International Congress on Gynecology Conferences & Gynecologic Oncology Conferences; 29th Cancer Therapy Conferences and Radiation Oncology Conferences, July 23-25, 2018 Rome, Italy; 28th Euro Cancer Science and Therapy Conferences, August 09-10, 2018 Madrid, Spain, May 10-12, 2018 Frankfurt, Germany; 9th European Immunology Conferences , June 14-16, 2018 Rome, Italy; 12th World Hematologists Conferences , March 15-16, 2018 London, UK; 14th International Surgical Pathology Conferences and Cancer Diagnosis Conferences, May 17-18, 2018 Rome, Italy; 7th World Breast Cancer Conferences, May 10-11, 2018 Frankfurt, Germany; 20th International Pediatrics Primary Care Conferences, September 03-04, 2018 Zurich, Switzerland; Annual Conference on Clinical Conferences and Medical Case Reports in Cardiology Conferences, July 05-06, 2018 Frankfurt, Germany; 47^th Global Nursing and Healthcare Conferences, March 01-03, 2018, London, UK; 7^th World Breast Cancer Conferences, May 10-11, 2018, Frankfurt, Germany; 26th Cancer Nursing & Nurse Practitioners Conferences, July 16-17, 2018, London, UK; 2nd World Patient Safety & Quality Healthcare Conferences, June 21-22, 2018, Dublin, Ireland

Track 20: Gynecology Oncology: Research

Cancer research defines basic research in cancer which is used in identifying the causes of cancer and developing novel strategies and new therapeutics for prevention, diagnosis, treatment, and cure of cancer. Nowadays clinical cancer research has shifted towards therapies like cancer immunotherapy and gene therapy.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 21: Gynecology and Oncology Nursing

With the current challenges in the healthcare system, patients and professionals are uncertain about the role, responsibilities, and communication patterns of primary care professionals during cancer care. Oncology and primary care nurses should be surveyed to attain current and preferred roles in cancer care across the care continuum.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Related Conferences: FIGO XXII World Congress of Gynecology & Obstetrics, October 14-19, 2018, Rio de Janeiro, Brazil; Maternal-Fetal Imaging 2018: Advances in OB-GYN Ultrasound, January 19-21, 2018, San Antonio, Texas; East Meets West: Cutting Edge in Fertility Science, February 02, 2018, Dubai, UAE; Obstetrics and Gynecology Conferences 2018, March 18-23, 2018, Boston, MA, United States; 15th Congress of the European Society of Contraception and Reproductive Health, May 09-12, 2018, Budapest, Hungary; 61st AICOG 2018 Conference, January 17-21, Bhubaneswar, India; Focus on Women's Health CME Conference, July 16-19, 2018, Kiawah Island, South Carolina, United States;18th World Congress International Society of Gynecological Endocrinology, March 07-10, 2018, Firenze, Italy; 26th European Board & College, Congress of Obstetrics and Gynecology (EBCOG), March 08-10, 2018, Paris, France; World Congress on Gynecology and Obstetrics, April 16-17, 2018, Dubai, UAE ; World Congress on Gynecology & Obstetrics, September 20-21, 2018 at Toronto, Canada; Obstetrics & Gynecology Conference, March 9, 2018, Los Angeles, USA; Gynecology Congress 2018, April 23 - 25, 2018, Valencia, Spain

Track 22: Health-Related Behaviours in Women

Behavioral Health is an extensive branch of interdisciplinary health which focuses widely on the reciprocal relationship between the characteristic view of human behaviour and well-being of the body entity. Behavioral Health is stated as the issues that can have a different outcome by changing behaviour. For example, giving up smoking can lessen the illnesses or Health Problems associated with cigarette smoking as discussed in many gynecologic conferences and gynecologic meetings worldwide. Many health conditions are caused by risk behaviours, such as, smoking, reckless driving, problem drinking, substance use, overreacting, or unprotected sexual intercourse. Fortunately, human beings have control over their conduct. Health-compromising behaviours can be eradicated by self-regulatory efforts and health enhancing behaviours that can be adopted such as preventive nutrition, physical exercise, weight control, dental hygiene, condom use or accident prevention.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Track 23: Sexual and Reproductive Health and Rights

Women’s sexual and regenerative wellbeing is identified with various human rights, including the privilege to life, the privilege to be free from torment, the privilege to wellbeing, the privilege to protection, the privilege to training, and the disallowance of segregation. Sexual and regenerative wellbeing and rights or SRHR is the idea of human rights connected to sexuality and generation. It is a mix of four fields that in a few settings are pretty much particular from each other, however less so or not in the slightest degree in different settings. These four fields are sexual wellbeing, sexual rights, regenerative wellbeing and conceptive rights. In the idea of SRHR, these four fields are dealt with as isolated however characteristically entwined.

Gynecology Conferences | Gynecology Oncology Conferences | Gynecology Cancer Conferences

Summary

Gynecology Meeting 2018 is the field of medicine that focuses on diseases and cancers of the female generative system. As experts they have wide training in the diagnosis and treatment in this field. In 2012, there were about 4.7 million cases of women cancer worldwide in which 54% cases arose in less developed countries. Although the occurrence and mortality from Gynecologic cancer are major, other cancers are very uncommon. Primary cancers of the vulva, vagina, placenta and adnexa total 0.6% of all woman cancers.

Gynecology Statistics

In the world 82,000 women are identified with Gynecologic diseases each year. In 2013, an expected 91,730 were diagnosed. An estimated 88,000 new cases of Gynecologic Diseases were expected to be diagnosed in 2014 in the Europe, and over 29,000 females will lose their battle with this deadly disease. In addition to imposing a significant load on patients and their relations, Gynecologic Abnormalities place a major burden on the health care organization. Cancer-related diseases and death for advanced and recurrent Gynecologic Cancer malignancies remain at intolerable stages. Every woman is at risk for emerging a Gynecologic Cancer. It is expected that there will be about 98,000 new cases diagnosed and around 30,000 deaths from Gynecologic Cancer in the Italy during 2015.

Scope and Importance of Gynecology Research

Gynecologic Anomalities and cancers are the third most commonly diagnosed disease and the leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Early detection of tumour biology and treatment of Gynecologic Cancer in younger women is more as compared to older women. Effort was devoted to the type of problems met in conducting the analyses and, where data were inadequate, recommending research guidelines or approaches.

Physicians are also involved in leading-edge programs in the prevention of cervical and Gynecologic Cancer through regular screenings and the identification of precancerous cervical lesions associated with papilloma virus infections.

Organized screening procedures can support to detect Gynecologic Cancer

Members Associated Gynecology Research

Gynecology research associated members in Rome are about 418, in Italy 5684 members and worldwide about 10214 research members.

Hospitals Associated with Gynecology Research

Major Gynecologic Cancer associated hospitals in Rome are around 3% when compared to worldwide.

Hospitals in Europe are:

St James Institute of Oncology

Velindre Cancer Centre

St Mary's Hospital

Glenfield Hospital

Cancer Research UK Manchester Institute

Glan Clwyd Hospital

University of London - The Institute of Cancer

Trafford General Hospital

Wythenshawe Hospital

Spire Manchester Hospital

The Christie

The Royal Marsden Hospital

UCL Cancer Institute

Weston Park Hospital

The Clatter Bridge Cancer Centre

UCH Macmillan Cancer Centre

Edinburgh Cancer Research Centre

Mount Vernon Cancer Centre

Elstree Cancer Centre

Parkside Hospital and Cancer Centre London

HCA Hospitals

The Royal Marsden

Queen Elizabeth Hospital

Papworth Clinic

Societies Associated with Gynecology Research

In world there are about 9,685 societies which are specifically associated with Gynecologic Cancer, in which 1289 societies are from Europe and the remaining 269 societies are from Rome.

Association of European Cancer Leagues ECL

The European Consortium for Cervical Cancer Education

National Cancer Institute

Macmillan Cancer Support

Europe European Association for Neuro Oncology EANO

Europe European Breast Cancer Coalition EUROPA DONNA

Europe European Cancer Organization ECCO

Europe European Group for Blood and Marrow Transplantation EBMT

Europe European Musculo-Skeletal Oncology Society EMOS

Europe European Network of Cancer Registries

Europe European Neurofibromatosis Association

Europe European Oncology Nursing Society EONS

Europe European Organization for Research and Treatment of Cancer.

Europe European Organization for Research and Treatment of Cancer-Gynecological Cancer Group

EORTC Gynecologic Oncology

Europe European Organization for Treatment of Trophoblastic Disease

Europe European Prostate Cancer Coalition

Europe European Registry of Hereditary Pancreatitis and Familial

Europe European Research Organization on Genital Infection and

Europe European School of Oncology ESO

Europe European Society for Medical Oncology ESMO

Europe European Society for Therapeutic Radiation and Oncology

Industries Associated with Gynecology Research

Industries associated with Gynecologic Cancer over all the world is about 80% in which 14% of industries are in Italy and in Rome about 6%.

· Johnson & Johnson

· Novartis

· Roche

· Pfizer

· Sanofi

· Merck

· Bristol-myers squibb

· Eli Lilly

· Celgene

· Takeda

· AstraZeneca

· Bayer

· Amgen Celgene

· Otsuka

· Pharmacyclics

· Incyte

Universities Associated with Gynecology Research

Arcispedale S. Maria Nuova Hospital, Reggio Emilia, Italy

University Hospital San Martino- IST - National Institute for Cancer Research, Genoa, Italy

Oncological Referral Center - National Cancer Institute, Aviano Italy

Oncological Referral Center of Basilicata Rionero in Vulture, Italy

European Institute of Oncology Milan Italy

San Raffaele Hospital in Milan Italy

Institute of Molecular Oncology Milan Italy

Institute for Pharmacological Research Mario Negri, Milan Italy

National Institute for the Study and Treatment of Cancer Foundation G.Pascale ' Milan Italy

Oncology Institute Veneto Italy

Institute Regina Elena / Regina Elena Cancer Institute, Rome Italy

Romagnolo Scientific Institute for Treatment of Cancer Italy

Institute of Oncology, Italy

The International Neuroscience Institute Hannover, Gerniar

Gustave Roussy Institute Villejuif Paris

Market Value on Gynecology Research

The global Gynecologic Cancer market in 2010 was valued at $54bn, an increase of 5.1% over the previous year‘s sales of $51.3bn, and is forecasted to grow at a CAGR of 6.9% from 2010–16, reaching $81bn in 2016.

· Collectively, the seven major markets (US, 5EU, and Japan) represented 79.1% (or $43bn) of in the global cancer market in 2010. In terms of size, the US dominated the global cancer market, with 2010 sales of $21bn and a market share of 38.5%.

· The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector. Collectively, the leading 10 brands accounted for almost 58.2% (or $31.4bn) of the global cancer market in 2010.

· In 2010 antineoplastics was the leading drug class in the global cancer market. The global antineoplastic market was valued at $46bn in 2010 at a year-on-year (Y-o-Y) growth of 7.3%. The major drugs that contributed to the 2010 sales in the antineoplastic category were Roche‘s Avastin (bevacizumab) at $6.2bn, Herceptin (trastuzumab) at $5.2bn, and MabThera (rituximab) at $5.1bn, with Y-o-Y sales growth of 3.8%, 3.1%, and 3.3% respectively.

· The cytostatic hormonal market registered 2010 sales of $8bn at a Y-o-Y decline of 6.5%. AstraZeneca‘s Arimidex (anastrozole) and Novartis‘s Femara (letrozole) led this class, reaching sales of $1.5bn and $1.3bn respectively in 2010

Market Growth of Gynecology Research in the last and upcoming ten years

Tech Navio's analysts forecast the Global Gynecologic Cancer market to grow at a CAGR of 12.47% over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of Gynecologic Cancer. The Global Gynecologic Cancer market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market. In next ten years as population ages, the number of people diagnosed with cancer is expected to be double. The volume of cancer services continues to grow. Radiation therapy by 3%,infusion therapy by 7%;Gynecologic services by 10%(annually).With earlier detection, cancer patients will be identified earlier with improvements in chemotherapy, patients will be able to tolerate more treatments, all of which will result in more treatments per patient and more lives saved.

Products manufactured by the industry related Gynecology Research

Market Value:

· Neosar (Cyclophosphamide)- manufactured by Roxane Laboratories Inc and the market value is

17.06$

· Paraplat (Carboplatin)-manufactured by Bristol-Myers Squibb Company and the market value is128$

· Platinol (Cisplatin)-manufactured by Bristol-Myers Squibb Company and the market value is15.3$

· Gemzar (Gemcitabine Hydrochloride)-manufactured by Eli Lilly and Company and the market value is 26.1$

· Clafen (Cyclophosphamide)-manufactured by Selleckchem and the market value is150$

Summary

Gynecology Statistics

Scope and Importance of Gynecology Research

Organized screening procedures can support to detect Gynecologic Cancer

Members Associated Gynecology Research

Gynecology research associated members in Rome are about 418, in Italy 5684 members and worldwide about 10214 research members.

Hospitals Associated with Gynecology Research

Major Gynecologic Cancer associated hospitals in Rome are around 3% when compared to worldwide.

Hospitals in Europe are:

St James Institute of Oncology

Velindre Cancer Centre

St Mary's Hospital

Glenfield Hospital

Cancer Research UK Manchester Institute

Glan Clwyd Hospital

University of London - The Institute of Cancer

Trafford General Hospital

Wythenshawe Hospital

Spire Manchester Hospital

The Christie

The Royal Marsden Hospital

UCL Cancer Institute

Weston Park Hospital

The Clatter Bridge Cancer Centre

UCH Macmillan Cancer Centre

Edinburgh Cancer Research Centre

Mount Vernon Cancer Centre

Elstree Cancer Centre

Parkside Hospital and Cancer Centre London

HCA Hospitals

The Royal Marsden

Queen Elizabeth Hospital

Papworth Clinic

Societies Associated with Gynecology Research

In world there are about 9,685 societies which are specifically associated with Gynecologic Cancer, in which 1289 societies are from Europe and the remaining 269 societies are from Rome.

Association of European Cancer Leagues ECL

The European Consortium for Cervical Cancer Education

National Cancer Institute

Macmillan Cancer Support

Europe European Association for Neuro Oncology EANO

Europe European Breast Cancer Coalition EUROPA DONNA

Europe European Cancer Organization ECCO

Europe European Group for Blood and Marrow Transplantation EBMT

Europe European Musculo-Skeletal Oncology Society EMOS

Europe European Network of Cancer Registries

Europe European Neurofibromatosis Association

Europe European Oncology Nursing Society EONS

Europe European Organization for Research and Treatment of Cancer.

Europe European Organization for Research and Treatment of Cancer-Gynecological Cancer Group

EORTC Gynecologic Oncology

Europe European Organization for Treatment of Trophoblastic Disease

Europe European Prostate Cancer Coalition

Europe European Registry of Hereditary Pancreatitis and Familial

Europe European Research Organization on Genital Infection and

Europe European School of Oncology ESO

Europe European Society for Medical Oncology ESMO

Europe European Society for Therapeutic Radiation and Oncology

Industries Associated with Gynecology Research

Industries associated with Gynecologic Cancer over all the world is about 80% in which 14% of industries are in Italy and in Rome about 6%.

· Johnson & Johnson

· Novartis

· Roche

· Pfizer

· Sanofi

· Merck

· Bristol-myers squibb

· Eli Lilly

· Celgene

· Takeda

· AstraZeneca

· Bayer

· Amgen Celgene

· Otsuka

· Pharmacyclics

· Incyte

Universities Associated with Gynecology Research

Arcispedale S. Maria Nuova Hospital, Reggio Emilia, Italy

University Hospital San Martino- IST - National Institute for Cancer Research, Genoa, Italy

Oncological Referral Center - National Cancer Institute, Aviano Italy

Oncological Referral Center of Basilicata Rionero in Vulture, Italy

European Institute of Oncology Milan Italy

San Raffaele Hospital in Milan Italy

Institute of Molecular Oncology Milan Italy

Institute for Pharmacological Research Mario Negri, Milan Italy

National Institute for the Study and Treatment of Cancer Foundation G.Pascale ' Milan Italy

Oncology Institute Veneto Italy

Institute Regina Elena / Regina Elena Cancer Institute, Rome Italy

Romagnolo Scientific Institute for Treatment of Cancer Italy

Institute of Oncology, Italy

The International Neuroscience Institute Hannover, Gerniar

Gustave Roussy Institute Villejuif Paris

Market Value on Gynecology Research

Market Growth of Gynecology Research in the last and upcoming ten years

Products manufactured by the industry related Gynecology Research

Market Value:

· Neosar (Cyclophosphamide)- manufactured by Roxane Laboratories Inc and the market value is

17.06$

· Paraplat (Carboplatin)-manufactured by Bristol-Myers Squibb Company and the market value is128$

· Platinol (Cisplatin)-manufactured by Bristol-Myers Squibb Company and the market value is15.3$

· Gemzar (Gemcitabine Hydrochloride)-manufactured by Eli Lilly and Company and the market value is 26.1$

· Clafen (Cyclophosphamide)-manufactured by Selleckchem and the market value is150$

The success of the 6^th International Congress on Gynecology & Gynecologic Oncology conference has given us the prospect to bring the gathering one more time. ConferenceSeries llc Ltd hosted the Gynecology Meeting 2018 during July 23-24, 2018 at Rome, Italy. The conference was focused on Gynecology and Gynecologic Cancers Research studies with the theme “Defying the Burdens of Gynecology to Create a Better Tomorrow for Today’s Women”. The meeting occupied an area of comprehensive discussions on different topics like reproduction, infertility, cosmetic gynecology, ovarian cancer, breast cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

· Paul H Sugarbaker, MedStar Washington Cancer Institute,USA

· Süleyman EserdaÄŸ, International Society of Aesthetic Genital Surgery and Sexology ,Turkey

· Rafal Kuzlik, SaskaMed Clinic, Poland

· Daniel U. Reimer, Medical University Innsbruck, Austria

· Paulina Cegla, Greater Poland Cancer Centre, Poland

ConferenceSeries llc Ltd offers its heartfelt appreciation to Management Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with ConferenceSeries and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and witnessing the triumph of Gynecologic Cancer 2017, ConferenceSeries would like to announce the commencement of the “7th International Congress on Gynecology & Gynecologic Oncology” to be held during June 20-21, 2018 in London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gyneocology Research.

For More details: https://gynecologyconference.annualcongress.com/

Let us meet again @ Gynecology Meeting 2019

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 20-21, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

7^th International Meeting on Gynecology &Gynecologic Oncology June 20-21, 2019 London, UK

Recommended Global Reproductive Medicine & Women Healthcare Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Gynecology Meeting 2019

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues